drugset / Trial / NCT05407818
A Study of JNJ-63733657 in Healthy Chinese Participants
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to assess the pharmacokinetics (PK) of JNJ-63733657 following single intravenous (IV) dose administration in healthy Chinese participants.
Timeline
- Start
- 2022-06-27
- Primary completion
- 2022-08-02
- Completion
- 2022-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | posdinemab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.